<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Antimicrob Agents Chemother</journal-id><journal-id journal-id-type="pmc-domain-id">82</journal-id><journal-id journal-id-type="pmc-domain">aac</journal-id><journal-id journal-id-type="publisher-id">ANTIMICROB AGENTS CHEMOTHER</journal-id><journal-title-group><journal-title>Antimicrobial Agents and Chemotherapy</journal-title></journal-title-group><issn pub-type="ppub">0066-4804</issn><issn pub-type="epub">1098-6596</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC89759</article-id><article-id pub-id-type="pmcid-ver">PMC89759.1</article-id><article-id pub-id-type="pmcaid">89759</article-id><article-id pub-id-type="pmcaiid">89759</article-id><article-id pub-id-type="pmid">10681351</article-id><article-id pub-id-type="doi">10.1128/aac.44.3.756-759.2000</article-id><article-id pub-id-type="publisher-id">0229</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Antiviral Agents</subject></subj-group><series-title>Note</series-title></article-categories><title-group><article-title>Intravitreal, Retinal, and Central Nervous System Foscarnet Concentrations after Rapid Intravenous Administration to Rabbits</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>L&#243;pez-Cort&#233;s</surname><given-names initials="LF">Luis F.</given-names></name><xref ref-type="aff" rid="N0x98405b8.0x9e50c20">1</xref><xref ref-type="author-notes" rid="FN150">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ruiz-Valderas</surname><given-names initials="R">R.</given-names></name><xref ref-type="aff" rid="N0x98405b8.0x9e50c20">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lucero-Mu&#241;oz</surname><given-names initials="MJ">M. J.</given-names></name><xref ref-type="aff" rid="N0x98405b8.0x9e50c20">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cordero</surname><given-names initials="E">E.</given-names></name><xref ref-type="aff" rid="N0x98405b8.0x9e50c20">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pastor-Ramos</surname><given-names initials="MT">M. T.</given-names></name><xref ref-type="aff" rid="N0x98405b8.0x9e50c20">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marquez</surname><given-names initials="J">J.</given-names></name><xref ref-type="aff" rid="N0x98405b8.0x9e50c20">4</xref></contrib></contrib-group><aff id="N0x98405b8.0x9e50c20"> Infectious Diseases Service,<sup>1</sup> Department of Ophthalmology,<sup>3</sup> and  Department of Neurosurgery,<sup>4</sup> Hospital Universitario Virgen del Roc&#237;o, and  Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Seville,<sup>2</sup> Seville, Spain</aff><author-notes><fn id="FN150"><label>*</label><p>Corresponding author. Mailing address: Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen del Roc&#237;o, Avda. Manuel Siurot, s/n. 41013, Seville, Spain. Phone: 34-5-4248265. Fax: 34-5-4248184. E-mail: <email>lflopez@cica.es</email>.</p></fn></author-notes><pub-date pub-type="ppub"><month>3</month><year>2000</year></pub-date><volume>44</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">2482</issue-id><fpage>756</fpage><lpage>759</lpage><history><date date-type="received"><day>22</day><month>3</month><year>1999</year></date><date date-type="rev-request"><day>16</day><month>10</month><year>1999</year></date><date date-type="accepted"><day>29</day><month>11</month><year>1999</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2000</year></date></event><event event-type="pmc-live"><date><day>12</day><month>09</month><year>2002</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-10-31 10:56:17.363"><day>31</day><month>10</month><year>2019</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2000, American Society for Microbiology</copyright-statement><copyright-year>2000</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ac000756.pdf"/><abstract><p>Retinal, vitreous humor, brain, and cerebrospinal fluid (CSF) foscarnet levels were measured by high-performance liquid chromatography after administration of an intravenous dose of 120 mg/kg of body weight to 32 pigmented rabbits. A pharmacokinetic analysis was done using a two-compartment model. The penetration ratios, defined as ratios of retinal, vitreous humor, brain, and CSF areas under the concentration-time curve from 0 to 2 h were 110% &#177; 1%, 12.3% &#177; 0.7%, 118% &#177; 1%, and 20.2% &#177; 2.2%, respectively. These results suggest a good penetration of foscarnet into the retinal and brain tissues, reaching higher concentrations than those estimated from vitreous humor and CSF levels.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>